Saurav Chemicals Limited has officially received the Eudra GMP Certification from the French National Agency for the safety of Medicine and Health Products (ANSM)        |        Saurav Chemicals Limited has received official approval from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for Clopidogrel Hydrogen Sulfate        |        Unlock Potential with AI and Machine Learning Solutions at Saurav Chemicals Limited

SCL Knowledge Centre

  • Home
  • SCL Knowledge Centre
The SCL Knowledge Centre aims to be the fountainhead of all future businesses of the SCL group. This will be achieved through an intense development effort on various streams of novel and futuristic applications for the life sciences industry. Saurav Chemicals Limited has acquired land at the ICICI Knowledge Park at Genome Valley near Hyderabad to establish this Centre. The Centre will house development facilities to aid the emerging needs of preventive medicines and to help SCL overcome the volatility caused by worldwide events through parallel development of several value-added business streams.

The developments carried out at the Knowledge Centre will help commercialize these avenues for the growth and sustainability of SCL. We offer Services in development and design of IVT Reaction Reagents and enzymes.

With the idea to encourage and enable creativity, it was intentionally planned to locate the Knowledge Centre away from the operational hub of SCL’s manufacturing facilities in Punjab.

Over the next few years, this Centre will create a pipeline of products for CDMO/CRO clients, focusing on niche API segments and developing specialty and performance chemicals which will find use in cutting-edge applications in several industries. One of the key verticals at the SCL Knowledge Centre will be focused on the development of a portfolio of ingredients/components for new applications in the vaccine industry.

To be located in Hyderabad, the Centre will be the source of all IP generation for SCL and will feed the pipelines of the verticals planned by SCL.

The Centre will provide SCL the flexibility to focus on innovative product development.
It will serve to showcase SCL's developmental range to international partners.
It will generate a pipeline for the three verticals of SCL, consisting of: CDMO & niche products, vaccine ingredients, and specialty/performance chemicals.
All assets and IP will be owned by SCL, thus adding to its worth and brand.
It is located close to a high-quality academic and research environment.
It will help SCL build a new culture and develop an internal pool of talent.

Get In Touch